Wang Jiajing
Department of Anesthesiology, Nanfang Hospital, Southern Medical University, The key Laboratory of Precision Anesthesia & perioperative Organ Protection, Guangzhou, 510515, Guangdong, China.
Department of Anesthesiology, Zengcheng Campus Nanfang Hospital, Southern Medical University, Guangzhou, 511338, Guangdong, China.
Scand J Trauma Resusc Emerg Med. 2025 May 13;33(1):84. doi: 10.1186/s13049-025-01403-5.
This comment critiques a trial comparing intranasal dexmedetomidine (DEX) and esketamine (sKET) for pediatric procedural sedation. Despite a large effect size, the small sample (n = 29) likely caused false-negative results (p = 0.09), necessitating larger trials. Safety concerns (e.g., aspiration risk), unaddressed long-term psychological outcomes, and limited pharmacokinetic data (delayed DEX onset, prolonged duration) challenge clinical applicability. Future studies should integrate objective measures and long-term follow-up.
本评论对一项比较鼻内给予右美托咪定(DEX)和艾司氯胺酮(sKET)用于儿科程序性镇静的试验进行了批评。尽管效应量较大,但小样本量(n = 29)可能导致了假阴性结果(p = 0.09),因此需要进行更大规模的试验。安全问题(如误吸风险)、未解决的长期心理结果以及有限的药代动力学数据(DEX起效延迟、持续时间延长)对临床适用性提出了挑战。未来的研究应纳入客观测量和长期随访。